Quoin Pharmaceuticals Ltd ADR (NASDAQ: QNRX) on Monday, soared 6.23% from the previous trading day, before settling in for the closing price of $0.60. Within the past 52 weeks, QNRX’s price has moved between $0.48 and $6.18.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 78.42%. With a float of $1.12 million, this company’s outstanding shares have now reached $5.05 million.
Let’s look at the performance matrix of the company that is accounted for 4 employees. In terms of profitability, gross margin is 50.81%, operating margin of -5948.33%, and the pretax margin is -5648.18%.
Quoin Pharmaceuticals Ltd ADR (QNRX) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The most recent insider transaction that took place on Sep 10 ’24, was worth 16,200. In this transaction Chief Financial Officer of this company bought 20,000 shares at a rate of $0.81, taking the stock ownership to the 28,856 shares. Before that another transaction happened on Sep 09 ’24, when Company’s Chief Financial Officer bought 8,856 for $0.79, making the entire transaction worth $7,005. This insider now owns 8,856 shares in total.
Quoin Pharmaceuticals Ltd ADR (QNRX) Latest Financial update
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -2.08 earnings per share (EPS) for the period topping the consensus outlook (set at -2.32) by 0.23. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.42 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 78.42% per share during the next fiscal year.
Quoin Pharmaceuticals Ltd ADR (NASDAQ: QNRX) Trading Performance Indicators
Quoin Pharmaceuticals Ltd ADR (QNRX) is currently performing well based on its current performance indicators. A quick ratio of 3.02 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.08, a number that is poised to hit -0.46 in the next quarter and is forecasted to reach -1.48 in one year’s time.
Technical Analysis of Quoin Pharmaceuticals Ltd ADR (QNRX)
Quoin Pharmaceuticals Ltd ADR (NASDAQ: QNRX) saw its 5-day average volume 6.94 million, a positive change from its year-to-date volume of 1.06 million. As of the previous 9 days, the stock’s Stochastic %D was 20.73%. Additionally, its Average True Range was 0.12.
During the past 100 days, Quoin Pharmaceuticals Ltd ADR’s (QNRX) raw stochastic average was set at 14.66%, which indicates a significant increase from 8.34% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 49.13% in the past 14 days, which was lower than the 130.64% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6349, while its 200-day Moving Average is $0.8071. Nevertheless, the first resistance level for the watch stands at $1.1483 in the near term. At $1.6591, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.9383. If the price goes on to break the first support level at $0.3583, it is likely to go to the next support level at $0.0791.
Quoin Pharmaceuticals Ltd ADR (NASDAQ: QNRX) Key Stats
Market capitalization of the company is 3.22 million based on 5,050K outstanding shares. Right now, sales total 0 K and income totals -8,690 K. The company made 0 K in profit during its latest quarter, and -2,350 K in sales during its previous quarter.
